MKSI Form 144: Insider Plans Sale of 5,000 Shares Valued $650K
Form 144 filed for MKSI (MKS Inc) reports a proposed sale of 5,000 common shares through Fidelity Brokerage Services, valued at $650,000, with an approximate sale date of 09/18/2025 on NASDAQ.
Rhea-AI Filing Summary
Form 144 filed for MKSI (MKS Inc) reports a proposed sale of 5,000 common shares through Fidelity Brokerage Services, valued at $650,000, with an approximate sale date of 09/18/2025 on NASDAQ. The filing lists the securities' acquisition history: purchases under the ESPP on 05/28/2021 (89 shares) and 11/30/2021 (67 shares), and restricted stock vesting on 02/15/2022 (1,472 shares) and 02/15/2024 (3,372 shares). It also discloses a prior sale of 2,000 shares on 07/03/2025 with gross proceeds of $210,000. The filer attests there is no undisclosed material adverse information.
Positive
- Clear compliance with Rule 144 disclosure requirements including broker, share counts, and acquisition history
- Specific acquisition dates and nature of payment (ESPP purchases and restricted stock vesting) are provided
- Prior sale disclosed (2,000 shares on 07/03/2025 for $210,000), showing transparency about recent dispositions
Negative
- Insider selling activity with a proposed sale of 5,000 shares valued at $650,000, which may be viewed negatively by some investors
- No 10b5-1 plan date is indicated in the filing, so the sale does not appear tied to a pre-established trading plan
Insights
TL;DR: Insider plans a modest sale of 5,000 MKSI shares, previously selling 2,000 in July, disclosed per Rule 144.
The filing documents a proposed Rule 144 sale of 5,000 common shares via Fidelity valued at $650,000, with clear acquisition provenance including ESPP purchases and restricted stock vesting. The recent 2,000-share sale on 07/03/2025 for $210,000 is disclosed, showing prior disposition activity. This is a routine insider liquidity event; the filing contains no forward-looking estimates or operational details about the issuer.
TL;DR: Disclosure is compliant and specific, indicating adherence to Rule 144 reporting requirements.
The notice provides required broker, share-count, aggregate value, acquisition dates, and payment nature (cash and compensation). The signer affirms absence of undisclosed material adverse information, and no trading-plan date is indicated. From a governance perspective, the form meets disclosure norms but signals insider selling activity that investors may note.
FAQ
What does the MKSI Form 144 disclose about the proposed sale?
What prior sales by the seller are reported in the MKSI filing?
Is there a stated trading plan (Rule 10b5-1) for these sales?
Who is the broker handling the proposed MKSI sale?
AI-generated analysis. How Rhea-AI works. Not financial advice.